{"database": "lobbying", "table": "lobbying_activities", "rows": [[1547008, "f6104c3b-43e6-46db-a54a-5353cae18279", "Q2", "CAPITOL HILL CONSULTING GROUP", 72053, "WELLNESS PHARMACY", 2014, "second_quarter", "PHA", "Pharmaceutical Compounding and Accountability Act (S.959)\nThe Compound Clarity Act (HR 3089)\nThe Drug Quality and Security Act (HR 3204)\nIssues related to implementation of the Compounding Quality Act", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2014-07-08T16:19:28.337000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1547008"], "units": {}, "query_ms": 54.588192026130855, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}